Assistant Professor in the Department of Family Medicine and the Department of Oncology and Program Director of the third-year family physician oncology program at the University of Ottawa in Ontario.
Professor of Medicine and Chief of the Division of Gastroenterology and Hepatology at Oregon Health and Science University in Portland.
Can Fam Physician. 2019 Nov;65(11):784-789.
To review and summarize the recently developed Canadian Association of Gastroenterology screening recommendations for patients with a family history of colorectal cancer (CRC) or adenoma from a family medicine perspective.
A systematic review and meta-analysis was performed to synthesize knowledge regarding family history and CRC. The Cochrane Central Register of Controlled Trials, MEDLINE, and EMBASE were searched with the following MeSH terms: and Known hereditary syndromes were excluded. The Grading of Recommendations Assessment, Development and Evaluation methodology was used to establish certainty in reviewed evidence. Most recommendations are conditional recommendations with very low-quality evidence.
Individuals who have 1 first-degree relative (FDR) with CRC or an advanced adenoma diagnosed at any age are recommended to undergo colonoscopy every 5 to 10 years starting at age 40 to 50 years or 10 years younger than the age at diagnosis of the FDR, although fecal immunochemical testing at an interval of every 1 to 2 years can be used. Individuals with FDRs with non-advanced adenomas or a history of CRC in second-degree relatives should be screened according to average-risk guidelines. Lifestyle modification can statistically significantly decrease risk of CRC and should be considered in all patients.
These guidelines acknowledge the many factors that can increase an individual's risk of developing CRC and allow for judgment to be employed depending on the clinical scenario. Lifestyle advice already given to patients for weight, blood pressure, and heart disease management will reduce the risk of CRC if implemented, and this combined with more targeted screening for higher-risk individuals will hopefully be successful in decreasing CRC mortality in Canada.
从家庭医学的角度回顾和总结加拿大胃肠病学会最近制定的针对有结直肠癌(CRC)或腺瘤家族史患者的筛查建议。
进行了系统评价和荟萃分析,以综合了解家族史和 CRC 相关知识。检索了 Cochrane 中央对照试验注册库、MEDLINE 和 EMBASE,使用以下 MeSH 术语: 和 排除已知遗传性综合征。使用推荐评估、制定和评估方法学(Grading of Recommendations Assessment, Development and Evaluation methodology)来确定审查证据的确定性。大多数建议都是有条件的建议,证据质量极低。
有 1 个一级亲属(FDR)患有 CRC 或任何年龄诊断出的晚期腺瘤的个体,建议从 40 至 50 岁或比 FDR 诊断年龄小 10 岁开始,每 5 至 10 年进行一次结肠镜检查,尽管可以每隔 1 至 2 年进行粪便免疫化学检测。有 FDR 患有非晚期腺瘤或二级亲属 CRC 病史的个体应根据一般风险指南进行筛查。生活方式的改变可以显著降低 CRC 的风险,应在所有患者中考虑。
这些指南承认了许多可以增加个体患 CRC 风险的因素,并根据临床情况进行判断。已经为患者提供了关于体重、血压和心脏病管理的生活方式建议,如果实施这些建议,将降低 CRC 的风险,并且将这些建议与更有针对性的高风险个体筛查相结合,有望成功降低加拿大 CRC 的死亡率。